Back to results
US 2023/0053563 A1Published application
Novel il2 agonists and methods of use thereof
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsJiaxi WU, Tong ZHANG, Maria del Pilar MOLINA-PORTELA, Eric Smith, Chia-Yang LIN, Thomas Craig Meagher
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to IL2 agonists with improved therapeutic profiles.
Claims68
An IL2 agonist comprising:
- (a) an Fc domain;
- an
- (b) an IL2 moiety C-terminal to the Fc domain, wherein the IL2 moiety comprises an IL2 domain and an IL2-Rα domain.
Dependencies are inferred from the claim text.